Dermata Therapeutics- Warrants (13/08/2026) Overview

Dermata Therapeutics- Warrants (13/08/2026) Profit Margin

See how DRMAW's profit margin trends over time vs similar companies.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

N/A

As of Mar 2026

Annual Profit Margin (TTM)

N/A

Trailing 12 months ending Mar 2026

Average Profit Margin (Comparison Companies)

Profit Margin History

Profit Margin Comparison

Annual Profit Margin Growth Rate (%)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin

Dermata Therapeutics- Warrants (13/08/2026) (DRMAW) FAQ

Stockcircle tracks profit margin for Dermata Therapeutics- Warrants (13/08/2026) (DRMAW), including historical charts and peer comparisons when data is available. Check back as new filings are published, or open the stock overview for a broader fundamental snapshot.

This Profit Margin page is built for Dermata Therapeutics- Warrants (13/08/2026)'s historical profit margin trend and peer context. When enough reporting periods are on file, the charts below visualize how the metric has moved over time.

Use profit margin as one input alongside growth, profitability, valuation, and ownership activity. Stockcircle links related metric pages and the main DRMAW overview so you can move from this figure to the surrounding analysis quickly.